| scholarly article | Q13442814 |
| P2093 | author name string | Huang Q | |
| Rao MS | |||
| Zhu Y | |||
| Reddy JK | |||
| Alvares K | |||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 26817-26820 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver | |
| P478 | volume | 268 |
| Q58914879 | A neutral risk on the development of new-onset diabetes mellitus (NODM) in Taiwanese patients with dyslipidaemia treated with fibrates |
| Q37382401 | Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. |
| Q28368383 | Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids |
| Q24631304 | Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha |
| Q37271252 | Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones |
| Q41591074 | Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression |
| Q34113175 | Association of DNA Methylation Levels with Tissue-specific Expression of Adipogenic and Lipogenic Genes in Longissimus dorsi Muscle of Korean Cattle |
| Q34418889 | Biochemistry of peroxisomes in health and disease |
| Q53619421 | Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans. |
| Q33826391 | Change of peroxisome proliferator-activated receptor γ expression pattern in the gerbil dentate gyrus after transient global cerebral ischemia |
| Q42625521 | Cloning and expression of the mouse deoxyuridine triphosphate nucleotidohydrolase gene: differs from the rat enzyme in that it lacks nuclear receptor interacting LXXLL motif. |
| Q36847488 | Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. |
| Q34191246 | Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice |
| Q37626440 | Current understanding of the role of PPARγ in gastrointestinal cancers |
| Q28508118 | Differential expression and activation of a family of murine peroxisome proliferator-activated receptors |
| Q28585053 | Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse |
| Q37417510 | Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity |
| Q24314755 | Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma |
| Q35752132 | Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor |
| Q40558581 | Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins |
| Q93064624 | Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2 |
| Q38295067 | Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus |
| Q71814194 | Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family |
| Q28343226 | Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma |
| Q34551679 | Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. |
| Q26739984 | Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases? |
| Q24563662 | Isolation of the human peroxisomal acyl-CoA oxidase gene: organization, promoter analysis, and chromosomal localization |
| Q28303529 | Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping |
| Q37319591 | Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. |
| Q36570690 | Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks |
| Q44982357 | Localization of mouse peroxisome proliferator-activated receptor gamma on chromosome 6. |
| Q37169032 | MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells |
| Q35003403 | Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression |
| Q78222429 | New adipogenic cell lines derived from C3H10T1/2 |
| Q64230670 | Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease |
| Q36733873 | Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors |
| Q38768048 | Nuclear receptors and nonalcoholic fatty liver disease |
| Q37725708 | Orphan nuclear receptors as targets for drug development |
| Q35932617 | Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. |
| Q28618806 | PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene |
| Q42250957 | PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis. |
| Q41077493 | PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene |
| Q35768913 | PPARgamma as a new therapeutic target in inflammatory bowel diseases |
| Q36063081 | PPARgamma in human and mouse physiology |
| Q35187434 | PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. |
| Q37334975 | PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3. |
| Q39029023 | PPARs and nonalcoholic fatty liver disease |
| Q35053566 | PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation |
| Q92128876 | PPARs as Nuclear Receptors for Nutrient and Energy Metabolism |
| Q38704475 | Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease |
| Q34800455 | Peroxisome proliferator-activated receptor (PPAR) gene profiling uncovers insulin-like growth factor-1 as a PPARalpha target gene in cardioprotection |
| Q33850995 | Peroxisome proliferator-activated receptors in the cardiovascular system |
| Q35098336 | Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing |
| Q28379103 | Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression |
| Q36478649 | Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt |
| Q37263875 | Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types |
| Q37355728 | Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. |
| Q26825855 | Road to exercise mimetics: targeting nuclear receptors in skeletal muscle |
| Q27022548 | Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases |
| Q28345289 | Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells |
| Q43185880 | Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidences |
| Q39532764 | Significance of LRP and PPAR-gamma Expression in Lipomatous Soft Tissue Tumors |
| Q37377746 | Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus |
| Q34018199 | Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms |
| Q24652367 | Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators |
| Q93249947 | Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis |
| Q34737346 | Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. |
| Q37781280 | The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease |
| Q42065117 | The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. |
| Q36917728 | The effect of pioglitazone on the Alzheimer's disease-induced apoptosis in human umbilical vein endothelial cells |
| Q58696174 | The polymorphisms of the PPARD gene modify post-training body mass and biochemical parameter changes in women |
| Q36238973 | The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer |
| Q58748755 | Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes |
| Q58748789 | Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4 |
| Q41139927 | Transcription, adipocyte differentiation, and obesity |
| Q34101631 | Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase |
| Q28379255 | Troglitazone action is independent of adipose tissue |
| Q34625038 | Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities |
Search more.